BCM
CFRX

BlueCrest Capital Management’s ContraFect Corporation CFRX Stock Holding History

BlueCrest Capital Management’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-30
Closed -$39K – 2012
2018
Q1 		$39K Buy
+30
New +$37K ﹤0.01% 1429

Other funds holding CFRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BlueCrest Capital Management's CFRX Position: Q2 2018 in Review

BlueCrest Capital Management sold out of ContraFect Corporation (CFRX) in Q2 2018, closing a stake of 30 shares — an estimated $39K sold.

BlueCrest Capital Management first reported a position in CFRX in Q1 2018 and held it in 1 quarter. The position peaked at $39K in Q1 2018. 38 funds tracked by Wall St. Rank hold CFRX as of Q2 2018.

  • BlueCrest Capital Management reported no remaining ContraFect Corporation position as of Q2 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 30 ContraFect Corporation shares in Q2 2018, an estimated $39K.
  • BlueCrest Capital Management first reported a position in ContraFect Corporation in Q1 2018 and held it in 1 quarter.
  • BlueCrest Capital Management's ContraFect Corporation position peaked at $39K in Q1 2018.
  • 38 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2018.

Based on BlueCrest Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.